Laurion Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-79,763,520
| Closed | -$10.1M | – | 696 |
|
|
2020
Q4 | $10.1M | Buy |
79,763,520
+23,851,492
| +43% | +$3.02M | 0.08% | 55 |
|
|
2020
Q3 | $126M | Buy |
55,912,028
+7,745,865
| +16% | +$17.4M | 1.5% | 1 |
|
|
2020
Q2 | $172M | Buy |
48,166,163
+2,773,581
| +6% | +$9.93M | 1.94% | 2 |
|
|
2020
Q1 | $172M | Sell |
45,392,582
-4,588,909
| -9% | -$17.4M | 1.88% | 5 |
|
|
2019
Q4 | $150M | Buy |
+49,981,491
| New | +$150M | 1.16% | 2 |
|